pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1284 |
Genomic Coordinates | chr3: 71541970 - 71542089 |
Synonyms | MIRN1284, hsa-mir-1284, MIR1284 |
Description | Homo sapiens miR-1284 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1284 | ||||||||||||||||||||||||||||||||||||
Sequence | 30| UCUAUACAGACCCUGGCUUUUC |51 | ||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | EIF4A1 | ||||||||||||||||||||
Synonyms | DDX2A, EIF-4A, EIF4A, eIF-4A-I, eIF4A-I | ||||||||||||||||||||
Description | eukaryotic translation initiation factor 4A1 | ||||||||||||||||||||
Transcript | NM_001416 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on EIF4A1 | |||||||||||||||||||||
3'UTR of EIF4A1 (miRNA target sites are highlighted) |
>EIF4A1|NM_001416|3'UTR 1 GGGGCTGTCCTGCCACCCAGCCCCAGCCAGGGCTCAATCTCTGGGGGCTGAGGAGCAGCAGGAGGGGGGAGGGAAGGGAG 81 CCAAGGGATGGACATCTTGTCATTTTTTTTCTTTGAATAAATGTCACTTTTTGAGGCAAAAGAAGGAACCGTGAACATTT 161 TAGACACCCTTTTCTTTGGGGTAGGCTCTTGCCCCAGGCGCCGGCTCTTCTCCCAAAAAAAAAAAAAAAACACTAATCCA 241 TTTCCCTAACCTAGTAACCTCCAGATCCCAGAGGCTCTCCTCACCTCAGCTGAGCTCCTTTGAAAGTGATTCAAGGGACT 321 ATGTCACTCAGCCTCATTTGCTGGACCAAATCTGGAGGGAGAACCCCTAAAACCCCTAAGTGAGGTTGCCCAGGGGGTTG 401 TCCCCAGGTGGGGGGAAGCAGGGGAGAGAAAATGGTAGCCATTTTTACATTGTTTTGTATAGTATTTATTGATTCAGGAA 481 ACAAACACAAAATTCTGAATAAAATGACTTGGAAACTGCCAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Non-Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | xx |
Validation Method |
|
Conditions | SGC7901 |
Disease | 1973.0; gastric cancer |
Location of target site | 3'UTR |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
"miR-1284 can heighten the expression of MYC and reduce the expression of JUN
... - Cao W; Wei W; Zhan Z; Xie Y; Xiao Q, 2016, Oncology reports. |
Article |
- Cao W; Wei W; Zhan Z; Xie Y; Xiao Q - Oncology reports, 2016
Routine chemotherapy as an important treatment mode often can not be effective because of multidrug resistance (MDR). MicroRNA (miRNA) modulates the expression of a great number of genes, including MDR. In this study, the expression of miR-1284 was reduced in gastric cancer (GC) tissue specimens with metastasis and in vincristine-resistant (VCR) GC SGC7901 cells (SGC-7901/VCR) compared to that in the controls. Recombinant lentiviral vectors with miR-1284 led to the overexpression of miR-1284 mRNA and reversed the chemoresistance of SGC7901/VCR cells, promoted cell cycle arrested at the G0/G1 phase, accelerated drug-induced apoptosis, and decreased migration and invasiveness of SGC-7901/VCR. In addition, the overexpression of miR-1284 sensitized tumors to chemotherapy in vivo. Our data provide combined evidence that miR-1284 can heighten the expression of MYC and reduce the expression of JUN, MMP12, and EIF4A1 that was the direct target. In conclusion, miR-1284 can function as a new regulator to reduce GC MDR cells by targeting EIF4A1.
LinkOut: [PMID: 26936591]
|
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
46 hsa-miR-1284 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT035831 | PRRC2B | proline rich coiled-coil 2B | 1 | 1 | ||||||||
MIRT079621 | DNAJB4 | DnaJ heat shock protein family (Hsp40) member B4 | 2 | 2 | ||||||||
MIRT149901 | LDLR | low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT182786 | TOR1AIP2 | torsin 1A interacting protein 2 | 2 | 2 | ||||||||
MIRT188827 | TMTC3 | transmembrane and tetratricopeptide repeat containing 3 | 2 | 2 | ||||||||
MIRT198187 | EIF4A1 | eukaryotic translation initiation factor 4A1 | 3 | 1 | ||||||||
MIRT245472 | ARID5B | AT-rich interaction domain 5B | 2 | 2 | ||||||||
MIRT252245 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 6 | ||||||||
MIRT269363 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 2 | ||||||||
MIRT320406 | HOXA9 | homeobox A9 | 2 | 4 | ||||||||
MIRT474722 | KIF13A | kinesin family member 13A | 2 | 6 | ||||||||
MIRT497926 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT504264 | C1orf147 | chromosome 1 open reading frame 147 | 2 | 4 | ||||||||
MIRT520449 | TSPAN2 | tetraspanin 2 | 2 | 4 | ||||||||
MIRT524092 | DNAJB14 | DnaJ heat shock protein family (Hsp40) member B14 | 2 | 4 | ||||||||
MIRT528639 | SENP6 | SUMO1/sentrin specific peptidase 6 | 2 | 2 | ||||||||
MIRT537385 | FGF2 | fibroblast growth factor 2 | 2 | 2 | ||||||||
MIRT538902 | BRI3BP | BRI3 binding protein | 2 | 2 | ||||||||
MIRT542095 | KCNK10 | potassium two pore domain channel subfamily K member 10 | 2 | 6 | ||||||||
MIRT543976 | PRR23A | proline rich 23A | 2 | 2 | ||||||||
MIRT549625 | ADCYAP1 | adenylate cyclase activating polypeptide 1 | 2 | 4 | ||||||||
MIRT554298 | SIPA1L2 | signal induced proliferation associated 1 like 2 | 2 | 2 | ||||||||
MIRT554872 | RCAN2 | regulator of calcineurin 2 | 2 | 2 | ||||||||
MIRT567623 | FAM210A | family with sequence similarity 210 member A | 2 | 2 | ||||||||
MIRT571137 | TTC33 | tetratricopeptide repeat domain 33 | 2 | 2 | ||||||||
MIRT576361 | Pxdn | peroxidasin | 2 | 2 | ||||||||
MIRT611088 | PHF8 | PHD finger protein 8 | 2 | 2 | ||||||||
MIRT612380 | TCTE1 | t-complex-associated-testis-expressed 1 | 2 | 4 | ||||||||
MIRT613725 | MTPN | myotrophin | 2 | 2 | ||||||||
MIRT614627 | YAE1D1 | Yae1 domain containing 1 | 2 | 2 | ||||||||
MIRT615818 | KIAA1549L | KIAA1549 like | 2 | 2 | ||||||||
MIRT620949 | TBCK | TBC1 domain containing kinase | 2 | 2 | ||||||||
MIRT622339 | SCN4A | sodium voltage-gated channel alpha subunit 4 | 2 | 2 | ||||||||
MIRT623219 | MTA3 | metastasis associated 1 family member 3 | 2 | 4 | ||||||||
MIRT628932 | SLC1A4 | solute carrier family 1 member 4 | 2 | 2 | ||||||||
MIRT632121 | FKBP9 | FK506 binding protein 9 | 2 | 2 | ||||||||
MIRT635877 | COX17 | COX17, cytochrome c oxidase copper chaperone | 2 | 2 | ||||||||
MIRT636485 | IKBKG | inhibitor of nuclear factor kappa B kinase subunit gamma | 2 | 2 | ||||||||
MIRT653097 | SRSF7 | serine and arginine rich splicing factor 7 | 2 | 2 | ||||||||
MIRT655048 | PKN2 | protein kinase N2 | 2 | 2 | ||||||||
MIRT686946 | SFT2D3 | SFT2 domain containing 3 | 2 | 2 | ||||||||
MIRT692724 | INPP5B | inositol polyphosphate-5-phosphatase B | 2 | 2 | ||||||||
MIRT697282 | ZNF800 | zinc finger protein 800 | 2 | 2 | ||||||||
MIRT698995 | SPAG9 | sperm associated antigen 9 | 2 | 2 | ||||||||
MIRT704462 | CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 2 | 2 | ||||||||
MIRT715163 | FIG4 | FIG4 phosphoinositide 5-phosphatase | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|